Loteprednol etabonate
Molecular Formula:
C24H31ClO7
InChI: InChI=1/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16u,17u,18-,19?,22-,23-,24-/m0/s1
InChIKey: InChIKey=DMKSVUSAATWOCU-DACWJQKVBY
SMILES: CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl
Names:
Alrex
CDDD 5604
chloromethyl (10S,11S,13S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
CHLOROMETHYL 17A-ETHOXYCARBONYLOXY-11B-HYDROXYANDROSTA-1,4-DIENE-3-ONE-17B-CARBO
HGP 1
Lotemax
Loteprednol etabonate Opphthalmic suspension
Loteprednol etabonate [USAN]
Loteprednol etabonate
P 5604
82034-46-6
Registries:
PubChem CID 54808
PubChem ID 192319
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|